Dr Reddys Labs Stock Sees Decline, Underperforms Sector by -1.7%

Dr Reddys Laboratories, a leading pharmaceutical company in the largecap industry, has recently seen a decline in its stock performance. On October 29, 2024, the company's stock lost -3.19%, underperforming the sector by -1.7%. This has led to a 'Hold' call by MarketsMOJO for the stock. The stock's price summary for the day shows that it touched an intraday low of Rs 1270.35, a decrease of -3.31%. Additionally, Dr Reddy's Labs is currently trading below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, indicating a downward trend in its stock price. In comparison to the overall market performance, Dr Reddys Laboratories has underperformed. On the same day, the Sensex's performance was -0.57%, while the stock's 1 day performance was -3.02%. Similarly, over the past month, the stock's performance was -5.57%, while the Sensex's performance was -7.04%. While the reasons for the decline in Dr Reddys Laboratories' stock performance are not mentioned, investors should keep an eye on the company's future developments and financial reports to make informed decisions about their investments. As of now, the stock's performance is not recommended for any action.